Home Finance Regeneron’s Antibody Drug Cut Risk of Covid-19 by 82%, Company Says

Regeneron’s Antibody Drug Cut Risk of Covid-19 by 82%, Company Says

29
0

Regeneron’s Antibody Drug Cut Danger of Covid-19 by 82%, Business States


< img srcset =" https://images.wsj.net/im-430953?width=540&size=1.5 540w, https://images.wsj.net/im-430953?width=620&size=1.5 620w, https://images.wsj.net/im-430953?width=639&size=1.5 639w, https://images.wsj.net/im-430953?width=860&size=1.5 860w, https://images.wsj.net/im-430953?width=860&size=1.5&pixel_ratio=1.5 1290w, https://images.wsj.net/im-430953?width=860&size=1.5&pixel_ratio=2 1720w, https://images.wsj.net/im-430953?width=860&size=1.5&pixel_ratio=3 2580w" src=" https://images.wsj.net/im-430953?width=860&height=573" design=" responsive" placeholder height=" 573 "width=" 860" alt > A coldbox containing monoclonal antibody treatments at a Regeneron center in Pembroke Pines, Fla., earlier this year.

Photo: Eva Marie Uzcategui/Bloomberg News

Published at Mon, 08 Nov 2021 15:31:00 +0000

https://www.wsj.com/articles/regenerons-antibody-drug-cut-risk-of-covid-19-by-82-company-says-11636385459?mod=pls_whats_news_us_business_f.

Previous articleThe Archbishop Has Spoken
Next articleLOL! Blake Lively, Ryan Reynolds’ Best Trolling Moments